St-101 clinical trials
Also written ST101.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses st-101 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- ST101
- 4
Studies by the year they started
4 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2011 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test st-101.
- Dec 2026A Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsPhase 1/2 · Sapience Therapeutics
Studies
Open first, then newest update. How each study uses st-101 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsActive, not recruitingPhase 1/2Sapience TherapeuticsNCT04478279Written as ST101
- Preliminary Efficacy and Safety Study of ST101 in Alzheimer's DiseaseCompletedPhase 2Sonexa Therapeutics, Inc.NCT00842673Written as ST101
- Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's DiseaseCompletedPhase 2Sonexa Therapeutics, Inc.NCT00842816Written as ST101
- A Pilot Efficacy and Safety Study of ST101 in Essential TremorCompletedPhase 2Sonexa Therapeutics, Inc.NCT01332695Written as ST101
Codes
What other systems call st-101 · ClinicalTrials.gg INT004929
- Wikidata Q27268838st-101One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27268838 | st-101 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.